相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
Carolyn D. Britten
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
MEK and the inhibitors: from bench to bedside
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
Patrick J. Roberts et al.
CLINICAL CANCER RESEARCH (2012)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential Therapies for KRAS Mutated Colorectal Cancer That Is Resistant to EGFR Monoclonal Antibody Therapy
Juyong Yoon et al.
CANCER RESEARCH (2011)
A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice
Natalya Lyubynska et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo
Kihyun Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia
MR Ricciardi et al.
LEUKEMIA (2005)
分享论文
